Clinical trial intelligence for enterprise AI ecosystems.

Vivo powers internal copilots, analytics workbenches, and agent ecosystems with governed, protocol-aware clinical trial intelligence. Vivo does not replace your internal AI strategy. It accelerates it.

The Opportunity

Enterprise AI needs clinical-trial-native intelligence.

BioPharma is investing in internal copilots, data platforms, analytics workbenches, and agent ecosystems. Clinical trial intelligence requires more than a generic AI interface — it requires live trial data, protocol context, role-aware access, source traceability, evidence generation, evaluation, auditability, and study integrity controls.

"The most interesting thing to us is the Ask Vivo. Could we have a solution like this focused on our own data warehouse?"

What Vivo Provides

Autonomous, API-first, and agent-to-agent ready.

30/60/90 Pilot Model

A practical path from evaluation to enterprise recommendation.

First 30 Days

Foundation

Select one active study. Identify priority data sources and use cases. Establish governance and access. Define success metrics and configure initial Ask Vivo question set.

By 60 Days

Working Intelligence Layer

Load and harmonize priority data. Configure role-aware Ask Vivo workflows. Demonstrate source-backed answers. Pilot recurring insights or alerts for priority risks.

By 90 Days

Evaluation & Expansion Plan

Measure insight quality, usefulness, adoption, and operational value. Define integration paths. Identify additional studies and use cases. Produce enterprise deployment recommendation.

Unlock Clinical-grade Enterprise AI.

Vivo gives large pharma teams a governed clinical trial intelligence layer that can power internal copilots, data platforms, analytics workbenches, and agent ecosystems.